Abstract：Objective To analyze effect of Cisplatin combined with Docetaxel in the treatment of non small cell lung cancer.Methods 42 patients with non small cell lung cancer treated in our hospital from January 2015 to June 2016 were selected as study group，and 42 patients with non small cell lung cancer from February to December in 2014 as control group.Patients in the control group were given combined treatment of Gemcitabine and Cisplatin，patients in the study group were treated by Docetaxel and Cisplatin，clinical efficacy，toxic and side effect，average disease progress time and average survival time in two groupswere observed and compared.Results After treatment，total efficiency rate in the study group was 85.71%，higher than 66.67%in the control group （P＜0.05）；occurrence rate of toxic and side effect in the study group had no significant difference compared with the control group （P＞0.05）；average disease progress time and average survival time in the study group were better than those in the control group （P＜0.05）.Conclusion Combined treatment of Gemcitabine and Cisplatin in patients with non small cell lung cancer hasmore significant therapeutic effect and high safety，which can be extended in clinic.
匡树根； 刘霞 ；刘铁兵 ；张轼 ；温钦生. 顺铂+多西他赛治疗非小细胞型肺癌患者的效果观察[J]. 中国当代医药, 2016, 23(26): 52-53转57.
KUANG Shu-gen； LIU Xia ；LIU Tie-bing ；ZHANG Shi ；WENQin-sheng. Effect observation of Cisplatin and Docetaxel in the treatment of patients with non small cell lung cancer. 中国当代医药, 2016, 23(26): 52-53转57.
Wu GD，Li HF，Ji ZY，et al.Inhibition of autophagy by autophagic inhibitors enhances apoptosis induced by bortezomib in non-small cell lung cancer cells［J］.Biotechnol Lett，2014，36（6）：1171-1178.［4］胡晓鸣，何刚，梅勇，等.改进型多西他赛注射液联合顺铂治疗晚期非小细胞肺癌的临床疗效和安全性分析［J］.医学信息，2015，28（6）：90-91.
京公网安备 11010502046607号